Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48.3Revenue $M0.5Net Margin (%)-4,597.6Z-Score-3.1
Enterprise Value $M13.6EPS $-1.0Operating Margin %-4,309.4F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-4,597.6Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %-10.4Quick Ratio4.7Cash flow > EarningsY
Price/Sales88.05-y EBITDA Growth Rate %-44.1Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-38.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-62.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M20.0ROI % (ttm)-69.0Gross Margin Increase y-yN

Gurus Latest Trades with CLSN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CLSN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CLSN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hooper Robert WDirector 2014-11-13Buy4,000$2.5-3.2view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.12-22.44view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.12-22.44view
Martinez Alberto R JrDirector 2014-08-15Buy5,000$3.12-22.44view
Fritz Frederick J.Director 2014-08-14Buy4,000$3.2-24.38view
Martinez Alberto R JrDirector 2014-06-26Buy5,000$3.36-27.98view
EGWU, Inc. fka EGEN, Inc.10% Owner 2014-06-20Sell0$0-27.98view
Martinez Alberto R JrDirector 2014-06-11Buy5,000$3.2-24.38view
Tardugno Michael HCEO 2014-06-11Buy5,000$3.2-24.38view
Fritz Frederick J.Director 2014-06-11Buy5,000$3.2-24.38view

Press Releases about CLSN :

    Quarterly/Annual Reports about CLSN:

    News about CLSN:

    Articles On GuruFocus.com
    Dead Biotech Plays Surge To Life May 07 2013 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 6,000 Shares Nov 19 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares Aug 17 2009 
    Celsion Reports Second Quarter 2009 Financial Results and Business Update Aug 05 2009 
    Celsion to Hold Second Quarter 2009 Financial Results Jul 31 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 3,750 Shares Mar 18 2009 
    Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for The Dec 16 2008 
    Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox® Dec 15 2008 

    More From Other Websites
    CELSION CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 10 2014
    CELSION CORP Financials Nov 18 2014
    10-Q for Celsion Corp. Nov 12 2014
    CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 12 2014
    Celsion Corporation Reports Third Quarter 2014 Financial Results Nov 11 2014
    Celsion Corporation Reports Third Quarter 2014 Financial Results Nov 11 2014
    CELSION CORP Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Celsion Corporation Receives VHP Approval to Initiate OPTIMA Study in Europe Nov 05 2014
    Celsion Corporation Receives VHP Approval to Initiate OPTIMA Study in Europe Nov 05 2014
    Celsion Corporation to Hold Third Quarter 2014 Financial Results Conference Call on Tuesday,... Nov 04 2014
    Celsion Corporation to Hold Third Quarter 2014 Financial Results Conference Call on Tuesday,... Nov 04 2014
    Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference... Oct 29 2014
    Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference... Oct 29 2014
    CELSION CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 07 2014
    Celsion Announces Appointment of Michael H. Tardugno to Executive Chairman of the Board of Directors Oct 07 2014
    Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board Oct 07 2014
    INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Celsion Corp.... Sep 17 2014
    Celsion Announces Highlights from Three Presentations Given at the International Liver Cancer... Sep 08 2014
    Celsion Reports Consolidated Duke University and Celsion's DIGNITY Study Clinical Data on... Sep 04 2014
    Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in... Sep 02 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK